Totally. Sirtex does not have the troubling issue of weakness and side effects of other treatments. This is definitely the future as more and more patients would rather treatments that are not painful and do not exhaust them during and after treatment. But man, it's all about the next breakout level. Found some pretty interesting technical analysis that shows an upturn very soon
- Forums
- ASX - By Stock
- Why OSL is a Multi-Bagger
OSL
oncosil medical ltd
Add to My Watchlist
6.84%
!
$1.02

Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $14.43M |
Open | High | Low | Value | Volume |
$1.00 | $1.03 | 96.0¢ | $23.22K | 23.59K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 1042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15628 | 0.950 |
2 | 1349 | 0.940 |
1 | 627 | 0.920 |
1 | 23 | 0.910 |
1 | 20000 | 0.905 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 1042 | 1 |
1.030 | 27 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.080 | 48 | 1 |
Last trade - 14.07pm 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
CDE
CODEIFAI LIMITED
John Houston / Martin Ross, Executive Chairman / COO
John Houston / Martin Ross
Executive Chairman / COO
Previous Video
Next Video
SPONSORED BY The Market Online